AXIC A — aXichem AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK125.64m
- SEK123.38m
- SEK18.45m
Brief: Axichem - Is Applying For Patent For Phenylcapsaicin For Treatment Of Ideopathic Pulmonary Fibrosis
Brief: aXichem Signs Agreement For Marketing And Distribution Of Axivite In Italy
Brief: aXichem Signs Agreement With Spanish Company Pharmafoods
Brief: aXichem Natural Analogue Capsaicin Shows Significant Effect In New Clinical Trial
Brief: Axichem Q1 Operating Loss Widens To SEK 3.2 Mln
Brief: aXichem Carries Out Directed Issue Of About SEK 19 Million
Brief: aXichem Gets New Patent
Brief: aXichem Q4 Operating Loss At SEK 3.5 Mln
Brief: aXichem Gets SEK 2 Mln Order From Chr. Olesen
Brief: aXichem: Product aXiphen Shows Good Results
Brief: aXichem Signs Agreement With Bart Regarding Distribution And Sales Of Axivite In Poland
Brief: aXichem Seeks Patent For Product
Brief: aXichem Q3 Operating Loss Widens To SEK 3.2 Mln
Brief: Axichem Q2 Pretax Loss Flat At SEK 3.7 Million
Brief: aXichem Obtains Order From Actives & Co For aXivite
Brief: aXichem Signs Distribution Agreement With Berg Nutrition
Brief: Axichem Q1 Operating Loss Widens To SEK 3.1 Mln
Brief: aXichem Signs Agreement With Actives & Co
Brief: aXichem Seeks Patent For Industrial Production Process Of Fenylcapsaicin